ClinicalTrials.Veeva

Menu

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Mount Sinai Health System logo

Mount Sinai Health System

Status

Enrolling

Conditions

Congenital Disorders of Glycosylation

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT04199000
Mayo 19-005187
U54NS115198-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this research is to study the natural history of congenital disorders of glycosylation and its causes and treatments.

Full description

The investigators are conducting a natural history study of patients with congenital disorders of glycosylation (CDG). The study will look into the progression of the disease amongst the participants and also look at the clinical symptoms and how they vary amongst different diseased population groups. The participants will be asked to fill out questionnaires either on their own or with a provider that will grade the severity of disease and document symptoms and diet. Participants will have an opportunity to submit blood, urine, and stool samples that will be tested for biomarkers for CDG.

Participants will also complete dietary food records, physical exams, CDG scores, and the PROMIS questionnaires to assess disease progression and severity.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals with a genetically, enzymatically, or molecularly confirmed diagnosis of CDG or NGLY1 deficiency

Exclusion criteria

  • None

Trial design

Trial documents
2

Trial contacts and locations

12

Loading...

Central trial contact

Mary Freeman, MS, CGC; Eva Morava-Kozicz, PhD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems